Cerus to Float Issue of Common Stock

Cerus (NASDAQ: CERS  ) will float a new offering of common stock in an underwritten public offering.The pharma company didn't disclose the number of shares that will be offered, nor did it specify how much it intended to raise from the issue. It did say that it intends to use the funds "for clinical development and other research and development activities" connected with its key product, the INTERCEPT Blood System.

Cerus added that it might use some of the proceeds to prepay outstanding monies owed to Comerica Bank for a growth capital loan.

Cowen Group's Cowen & Co. is the sole book-running manager for the issue.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2311882, ~/Articles/ArticleHandler.aspx, 4/17/2014 12:12:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement